Ömer Faruk Kalkan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ömer Faruk Kalkan has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Zafer Sahin
Department of Physiology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey
11 shared publications - Osman Aktaş
Department of Physiology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey
7 shared publications - Ali Yavuz Uzun
Karadeniz Technical University
5 shared publications Zafer Şahin
Karadeniz Technical University, Faculty of Medicine, Department of Physiology, Trabzon, Türkiye
5 shared publications- Abdulhamit Yildirim
Laboratory and Veterinary Assistance Services, Maçka Vocational School, Karadeniz Technical University, Trabzon, Turkey
3 shared publications - Abdullah Kaan Kurt
Department of Family Medicine, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey
3 shared publications
Latest Publications
- Open Access
- 15 April 2026
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 26 (1)
Association of pectoralis major muscle cross-sectional area and mean density on chest CT with mortality in elderly COVID-19 patients: sex and side differences
COVID-19 is a disease that primarily affects the lungs and may follow a fatal course. The aim of this study was to investigate whether there are difference
- 15 April 2026
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 26 (1)
Open AccessAssociation of pectoralis major muscle cross-sectional area and mean density on chest CT with mortality in elderly COVID-19 patients: sex and side differences
COVID-19 is a disease that primarily affects the lungs and may follow a fatal course. The aim of this study was to investigate whether there are difference
- 12 November 2025
- Published by Springer Nature in Biologia Futura
- Vol. 77 (1) , 155-164
Central administration of asprosin reduces baseline brain activity but does not attenuate 4-AP-induced epileptiform discharges: an in vivo electrophysiological study
In the current study, we investigated the effects of central asprosin administration on baseline brain activity and 4-aminopyridine (4-AP) induced epileptiform activity. Additionally, we examined the effects of asprosin on electrocorticography (ECoG) band powers. Forty-two male Wistar rats were divided into six groups as follows: sham, 4-AP (2.5 mg/kg i.p.), asprosin 20 nmol (i.c.v.), asprosin 50 nmol (i.c.v.), asprosin 50 nmol (i.c.v.) posttreatment, and asprosin 50 nmol (i.c.v.) pre-treatment. Recordings lasting 60–70 min were conducted for all groups under ketamine/xylazine (90/10 mg/kg) anesthesia. In the posttreatment group, asprosin was injected 20 min after the induction of epileptiform activity. In the pre-treatment group, asprosin was injected after baseline recordings, and following a 20-min pre-treatment period, 4-AP was administered. 4-AP alone induced epileptiform activity in all animals, peaking at approximately the 30th minute. Asprosin significantly reduced ECoG power at doses of 20 nmol and 50 nmol. Furthermore, both doses of asprosin reduced alpha, beta, delta, theta, and gamma band activity in ECoG recordings at various time points. However, asprosin pre- and posttreatment had no significant effect on 4-AP-induced epileptiform activity. These findings suggest that asprosin modulates cortical excitability under physiological conditions but is ineffective in attenuating induced epileptiform activity.
- 12 November 2025
- Published by Springer Nature in Biologia Futura
- Vol. 77 (1) , 155-164
Central administration of asprosin reduces baseline brain activity but does not attenuate 4-AP-induced epileptiform discharges: an in vivo electrophysiological study
In the current study, we investigated the effects of central asprosin administration on baseline brain activity and 4-aminopyridine (4-AP) induced epileptiform activity. Additionally, we examined the effects of asprosin on electrocorticography (ECoG) band powers. Forty-two male Wistar rats were divided into six groups as follows: sham, 4-AP (2.5 mg/kg i.p.), asprosin 20 nmol (i.c.v.), asprosin 50 nmol (i.c.v.), asprosin 50 nmol (i.c.v.) posttreatment, and asprosin 50 nmol (i.c.v.) pre-treatment. Recordings lasting 60–70 min were conducted for all groups under ketamine/xylazine (90/10 mg/kg) anesthesia. In the posttreatment group, asprosin was injected 20 min after the induction of epileptiform activity. In the pre-treatment group, asprosin was injected after baseline recordings, and following a 20-min pre-treatment period, 4-AP was administered. 4-AP alone induced epileptiform activity in all animals, peaking at approximately the 30th minute. Asprosin significantly reduced ECoG power at doses of 20 nmol and 50 nmol. Furthermore, both doses of asprosin reduced alpha, beta, delta, theta, and gamma band activity in ECoG recordings at various time points. However, asprosin pre- and posttreatment had no significant effect on 4-AP-induced epileptiform activity. These findings suggest that asprosin modulates cortical excitability under physiological conditions but is ineffective in attenuating induced epileptiform activity.
- 30 October 2025
- Published by Springer Nature in Neurochemical Research
- Vol. 50 (6) , 1-10
3-Carene Modulates Baseline Brain Electrical Activity Without Suppressing 4-Aminopyridine-Induced Seizure Events: An In Vivo and In Vitro Electrophysiological Study
In the current study, we investigated the effects of 3-carene administration on basal brain activity and 4-aminopyridine (4-AP) induced epileptiform activity. Additionally, we examined the effects of asprosin on ECoG band powers. Thirty-five male Wistar rats were divided into five groups as follows: control (DMSO), 4-AP (2.5 mg/kg i.p.), 3-carene 10 mg/kg (i.p), 3-carene 50 mg/kg (i.p), 3-carene 50 mg/kg (i.p) post-treatment. Recordings lasting 60–70 min were conducted for all groups under ketamine/xylazine (90/10 mg/kg) anesthesia. Furthermore, we used thick acute horizontal hippocampal slices obtained from 30‑ to 35‑day‑old rats for in vitro experiments. Extracellular field potential recordings were evaluated in the CA1 region of the hippocampus. In vivo recordings revealed that intraperitoneal administration of 3-carene (10 mg/kg and 50 mg/kg) significantly suppressed basal brain activity across delta, theta, alpha, and beta bands. However, 3-carene failed to reduce epileptiform discharges induced by 4-AP. Complementary in vitro experiments using hippocampal and entorhinal cortex slices further confirmed the lack of anticonvulsant effect, as 3-carene did not alter the frequency or duration of 4-AP-induced ictal or interictal events. These findings suggest that while 3-carene modulates resting-state cortical oscillations, it lacks efficacy in suppressing seizure-like activity. The results highlight its potential as a neuromodulatory agent rather than a standalone anticonvulsant.
- 30 October 2025
- Published by Springer Nature in Neurochemical Research
- Vol. 50 (6) , 1-10
3-Carene Modulates Baseline Brain Electrical Activity Without Suppressing 4-Aminopyridine-Induced Seizure Events: An In Vivo and In Vitro Electrophysiological Study
In the current study, we investigated the effects of 3-carene administration on basal brain activity and 4-aminopyridine (4-AP) induced epileptiform activity. Additionally, we examined the effects of asprosin on ECoG band powers. Thirty-five male Wistar rats were divided into five groups as follows: control (DMSO), 4-AP (2.5 mg/kg i.p.), 3-carene 10 mg/kg (i.p), 3-carene 50 mg/kg (i.p), 3-carene 50 mg/kg (i.p) post-treatment. Recordings lasting 60–70 min were conducted for all groups under ketamine/xylazine (90/10 mg/kg) anesthesia. Furthermore, we used thick acute horizontal hippocampal slices obtained from 30‑ to 35‑day‑old rats for in vitro experiments. Extracellular field potential recordings were evaluated in the CA1 region of the hippocampus. In vivo recordings revealed that intraperitoneal administration of 3-carene (10 mg/kg and 50 mg/kg) significantly suppressed basal brain activity across delta, theta, alpha, and beta bands. However, 3-carene failed to reduce epileptiform discharges induced by 4-AP. Complementary in vitro experiments using hippocampal and entorhinal cortex slices further confirmed the lack of anticonvulsant effect, as 3-carene did not alter the frequency or duration of 4-AP-induced ictal or interictal events. These findings suggest that while 3-carene modulates resting-state cortical oscillations, it lacks efficacy in suppressing seizure-like activity. The results highlight its potential as a neuromodulatory agent rather than a standalone anticonvulsant.
- 28 September 2025
- Published by Archives of Current Medical Research in Archives of Current Medical Research
- Vol. 6 (3) , 235-242
Central Kisspeptin Modulates Serum Ghrelin and Orexin A Levels Without Affecting Leptin: Interactions with CRH and Oxytocin/Vasopressin Pathways
Background: Kisspeptins, neuropeptides encoded by the KISS1 gene, play a critical role in regulating the hypothalamic-pituitary-gonadal (HPG) axis and have emerging links to metabolic regulation, energy balance, and feeding behaviour. The precise mechanisms by which kisspeptin influences key metabolic peptides such as leptin, ghrelin, and orexin-A remain unclear. This study investigates the metabolic effects of kisspeptin, exploring its interactions with stress-related neuropeptides, including corticotropin-releasing hormone (CRH), adrenocorticotropic hormone (ACTH), oxytocin, and vasopressin. Methods: Rats were randomly divided into seven groups (n = 10 per group): Sham (control), Kisspeptin (50 pmol), P234 (1 nmol), Kisspeptin + p234 (1 nmol), Kisspeptin + Antalarmin (0.1 μg), Kisspeptin + astressin-2B (1 μg), and Kisspeptin + Atosiban (300 ng). All treatments were administered via intracerebroventricular (ICV) injection. Rats were anesthetized with urethane (1.25 g/kg, i.p.). Serum was collected by decapitation after 30 minutes, and levels of orexin-A, ghrelin and leptin were measured using commercial ELISA kits. Results: Kisspeptin administration alone did not significantly affect plasma leptin levels (p > 0.05). However, kisspeptin significantly reduced serum ghrelin levels (40% reduction) (p < 0.05). Co-administration of kisspeptin with p234 (1100 pg/ml), antalarmin (1400 pg/ml), astressin-2B (1050 pg/ml), or atosiban (900 pg/ml) resulted in elevated ghrelin levels (p
- 28 September 2025
- Published by Archives of Current Medical Research in Archives of Current Medical Research
- Vol. 6 (3) , 235-242
Central Kisspeptin Modulates Serum Ghrelin and Orexin A Levels Without Affecting Leptin: Interactions with CRH and Oxytocin/Vasopressin Pathways
Background: Kisspeptins, neuropeptides encoded by the KISS1 gene, play a critical role in regulating the hypothalamic-pituitary-gonadal (HPG) axis and have emerging links to metabolic regulation, energy balance, and feeding behaviour. The precise mechanisms by which kisspeptin influences key metabolic peptides such as leptin, ghrelin, and orexin-A remain unclear. This study investigates the metabolic effects of kisspeptin, exploring its interactions with stress-related neuropeptides, including corticotropin-releasing hormone (CRH), adrenocorticotropic hormone (ACTH), oxytocin, and vasopressin. Methods: Rats were randomly divided into seven groups (n = 10 per group): Sham (control), Kisspeptin (50 pmol), P234 (1 nmol), Kisspeptin + p234 (1 nmol), Kisspeptin + Antalarmin (0.1 μg), Kisspeptin + astressin-2B (1 μg), and Kisspeptin + Atosiban (300 ng). All treatments were administered via intracerebroventricular (ICV) injection. Rats were anesthetized with urethane (1.25 g/kg, i.p.). Serum was collected by decapitation after 30 minutes, and levels of orexin-A, ghrelin and leptin were measured using commercial ELISA kits. Results: Kisspeptin administration alone did not significantly affect plasma leptin levels (p > 0.05). However, kisspeptin significantly reduced serum ghrelin levels (40% reduction) (p < 0.05). Co-administration of kisspeptin with p234 (1100 pg/ml), antalarmin (1400 pg/ml), astressin-2B (1050 pg/ml), or atosiban (900 pg/ml) resulted in elevated ghrelin levels (p
- 25 September 2025
- Published by Gumushane University in Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi
- Vol. 14 (3) , 878-885
İntraserebroventriküler Nesfatin-1 Enjeksiyonun Erkek Sıçanlarda Serum Ghrelin Leptin, Orexin A ve Asprosin Düzeylerine Etkisi
Hipotalamik alanlarda üretilen nesfatin-1 anoreksijenik bir peptittir. Nesfatin-1’in bu anoreksijenik etkisinde hipotalamo-hipofizer-adrenal aks aktivasyonu yanı sıra stres yanıtı da rol oynar. Nesfatin-1’in leptin, ghrelin, orexin-A ve asprosin gibi açlık-tokluk üzerinde önemli rol oyanayan nöropeptitler üzerinde nasıl bir etkiye sahip olduğu tam olarak aydınlatılmamıştır. Bu çalışmada, nesfatin-1’in CRH1, CRH2 ve oksitosin reseptör antagonistleriyle etkileşiminin, serum ghrelin, leptin, asprosin ve oreksin A düzeyleri üzerindeki etkilerini araştırmak hedeflenmiştir. Çalışmada toplam 42 adet erkek sıçan kullanılmış ve rastgele 6 gruba ayrılmıştır; (her grup için n=7): sham (kontrol), nesfatin-1, nesfatin-1 (25pmol) +P234 (1 nmol), nesfatin-1+antalarmin (0,1 μg), nesfatin-1+ astressin (1 μg) 2B, nesfatin-1+atosiban (300 ng). Tüm antagonistler introserebroventriküler yolla enjekte edilmiştir. Hayvanlar anestezi (1.25 g/kg, periton içi) altına alındıktan 30 dakika sonra dekapitasyonla sakrifiye edilmiştir. Serum örnekleri toplanmış ve leptin, ghrelin, orexin A ve asprosin seviyeleri ELISA ticari kitleri ile ölçülmüştür. Nesfatin-1’ tek başına uygulaması serum leptin, ghrelin, orexin-A ve asprosin seviyelerini değiştirmemiştir (p>0.05). Nesfatin-1’in P234 ile uygulaması orexin-A ve ghrelin seviyelerini azaltırken leptin seviyesini artırmıştır (p
- 25 September 2025
- Published by Gumushane University in Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi
- Vol. 14 (3) , 878-885
İntraserebroventriküler Nesfatin-1 Enjeksiyonun Erkek Sıçanlarda Serum Ghrelin Leptin, Orexin A ve Asprosin Düzeylerine Etkisi
Hipotalamik alanlarda üretilen nesfatin-1 anoreksijenik bir peptittir. Nesfatin-1’in bu anoreksijenik etkisinde hipotalamo-hipofizer-adrenal aks aktivasyonu yanı sıra stres yanıtı da rol oynar. Nesfatin-1’in leptin, ghrelin, orexin-A ve asprosin gibi açlık-tokluk üzerinde önemli rol oyanayan nöropeptitler üzerinde nasıl bir etkiye sahip olduğu tam olarak aydınlatılmamıştır. Bu çalışmada, nesfatin-1’in CRH1, CRH2 ve oksitosin reseptör antagonistleriyle etkileşiminin, serum ghrelin, leptin, asprosin ve oreksin A düzeyleri üzerindeki etkilerini araştırmak hedeflenmiştir. Çalışmada toplam 42 adet erkek sıçan kullanılmış ve rastgele 6 gruba ayrılmıştır; (her grup için n=7): sham (kontrol), nesfatin-1, nesfatin-1 (25pmol) +P234 (1 nmol), nesfatin-1+antalarmin (0,1 μg), nesfatin-1+ astressin (1 μg) 2B, nesfatin-1+atosiban (300 ng). Tüm antagonistler introserebroventriküler yolla enjekte edilmiştir. Hayvanlar anestezi (1.25 g/kg, periton içi) altına alındıktan 30 dakika sonra dekapitasyonla sakrifiye edilmiştir. Serum örnekleri toplanmış ve leptin, ghrelin, orexin A ve asprosin seviyeleri ELISA ticari kitleri ile ölçülmüştür. Nesfatin-1’ tek başına uygulaması serum leptin, ghrelin, orexin-A ve asprosin seviyelerini değiştirmemiştir (p>0.05). Nesfatin-1’in P234 ile uygulaması orexin-A ve ghrelin seviyelerini azaltırken leptin seviyesini artırmıştır (p
- Open Access
- 30 June 2025
- Published by University of Ljubljana in SLOVENIAN VETERINARY RESEARCH
- Vol. 62 (2) , 83-93
POMEGRANATE JUICE TREATMENT PREVENTS CARBON TETRACHLORIDE(CCL4)-INDUCED TESTICULAR DAMAGE IN RATS: A BIOCHEMICAL AND HISTOLOGICAL STUDY
We investigated the side effects of carbon tetrachloride (CCl4) on testicular tissue and explored the protective effects of pomegranate juice (PJ) against CCl4 exposure. Twenty-eight male Wistar albino rats were randomly divided into four groups as follows: Control, PJ, CCl4, and CCl4+PJ. We assessed serum testosterone levels and evaluated carboxylesterase (CaE), malondialdehyde (MDA), glutathione (GSH), glutathione reductase (GR) and glutathione Stransferase (GST) parameters. Histopathological changes were examined using CD68 immunoreactivity to detect macrophage activity. Analysis revealed a significant increase in CaE activity in the PJ group that compared to the control group (p < 0.05). CCl4 exposure reduced CaE activity, which was partially restored by PJ in the CCl4+PJ group (p < 0.05). PJ also significantly reduced the elevated MDA levels induced by CCl4 (p < 0.05). CCl4 alone decreased the reduced glutathione (GSH) levels (p < 0.05), however PJ had no effect on GSH levels (p > 0.05). Neither CCl4 nor PJ had an effect on glutathione reductase (GR) and glutathione S-transferase (GST) activity (p > 0.05). In conclusion, PJ reversed histological damage and restored reduced testosterone levels. Furthermore, it alleviated CCl4-induced oxidative stress by utilizing an alternative antioxidant system rather than glutathione.
- 30 June 2025
- Published by University of Ljubljana in SLOVENIAN VETERINARY RESEARCH
- Vol. 62 (2) , 83-93
Open AccessPOMEGRANATE JUICE TREATMENT PREVENTS CARBON TETRACHLORIDE(CCL4)-INDUCED TESTICULAR DAMAGE IN RATS: A BIOCHEMICAL AND HISTOLOGICAL STUDY
We investigated the side effects of carbon tetrachloride (CCl4) on testicular tissue and explored the protective effects of pomegranate juice (PJ) against CCl4 exposure. Twenty-eight male Wistar albino rats were randomly divided into four groups as follows: Control, PJ, CCl4, and CCl4+PJ. We assessed serum testosterone levels and evaluated carboxylesterase (CaE), malondialdehyde (MDA), glutathione (GSH), glutathione reductase (GR) and glutathione Stransferase (GST) parameters. Histopathological changes were examined using CD68 immunoreactivity to detect macrophage activity. Analysis revealed a significant increase in CaE activity in the PJ group that compared to the control group (p < 0.05). CCl4 exposure reduced CaE activity, which was partially restored by PJ in the CCl4+PJ group (p < 0.05). PJ also significantly reduced the elevated MDA levels induced by CCl4 (p < 0.05). CCl4 alone decreased the reduced glutathione (GSH) levels (p < 0.05), however PJ had no effect on GSH levels (p > 0.05). Neither CCl4 nor PJ had an effect on glutathione reductase (GR) and glutathione S-transferase (GST) activity (p > 0.05). In conclusion, PJ reversed histological damage and restored reduced testosterone levels. Furthermore, it alleviated CCl4-induced oxidative stress by utilizing an alternative antioxidant system rather than glutathione.
- 21 January 2025
- Published by Taylor & Francis in Neurological Research
- Vol. 47 (2) , 139-146
Central administration of p234, kisspeptin antagonist, but not kisspeptin-10, reduces the power of epileptiform activity and slow EEG waves in male rats
We aimed to investigate the effects of central kisspeptin-10 and p234 administration on basal brain activity and epilepsy-like conditions induced by 4-aminopyridine (4-AP), as well as their roles in the electrocorticogram (ECoG) power spectrum and EEG waves. Thirty-five male Wistar rats were divided into five groups: sham,4-AP (2.5 mg/kg i.p.), kisspeptin-10 post-treatment (200 pmoli.c.v.), p234 post-treatment (1 nmol i.c.v.), and p234 pre-treatment (1 nmol i.c.v.). We performed 70 minutes of recordings (10 min baseline) for all groups under ketamine/xylazine (90/10 mg/kg) anesthesia. In the post-treatment groups, kisspeptin-10 or p234 injections were administered 20 minutes after epilepsy induction. In the pre-treatment group, p234 was injected after baseline recordings. Following a 20-minute pre-treatment period, 4-AP was administered. 4-AP alone induced epileptiform activity in all animals, reaching apeak after 30 minutes. Neither kisspeptin-10 nor p234 post-treatment affected 4-AP-induced epileptiform activity (p > 0.05). However, p234 pre-treatment reduced epileptiform activity (p < 0.05). Additionally, kisspeptin-10 did not alter the spectral analysis of the EEG bands or the power of the ECoG (p > 0.05). In contrast, p234 reduced the power of the ECoG and the slow bands (delta and theta) (p < 0.05). We conclude that p234 pre-treatment has an inhibitory effect on neuronal excitability and epileptiform activity in the neocortex.
- 21 January 2025
- Published by Taylor & Francis in Neurological Research
- Vol. 47 (2) , 139-146
Central administration of p234, kisspeptin antagonist, but not kisspeptin-10, reduces the power of epileptiform activity and slow EEG waves in male rats
We aimed to investigate the effects of central kisspeptin-10 and p234 administration on basal brain activity and epilepsy-like conditions induced by 4-aminopyridine (4-AP), as well as their roles in the electrocorticogram (ECoG) power spectrum and EEG waves. Thirty-five male Wistar rats were divided into five groups: sham,4-AP (2.5 mg/kg i.p.), kisspeptin-10 post-treatment (200 pmoli.c.v.), p234 post-treatment (1 nmol i.c.v.), and p234 pre-treatment (1 nmol i.c.v.). We performed 70 minutes of recordings (10 min baseline) for all groups under ketamine/xylazine (90/10 mg/kg) anesthesia. In the post-treatment groups, kisspeptin-10 or p234 injections were administered 20 minutes after epilepsy induction. In the pre-treatment group, p234 was injected after baseline recordings. Following a 20-minute pre-treatment period, 4-AP was administered. 4-AP alone induced epileptiform activity in all animals, reaching apeak after 30 minutes. Neither kisspeptin-10 nor p234 post-treatment affected 4-AP-induced epileptiform activity (p > 0.05). However, p234 pre-treatment reduced epileptiform activity (p < 0.05). Additionally, kisspeptin-10 did not alter the spectral analysis of the EEG bands or the power of the ECoG (p > 0.05). In contrast, p234 reduced the power of the ECoG and the slow bands (delta and theta) (p < 0.05). We conclude that p234 pre-treatment has an inhibitory effect on neuronal excitability and epileptiform activity in the neocortex.
- 17 December 2024
- Published by National Institute of Public Health NIH (National Research Institute) in Roczniki Panstwowego Zakladu Higieny
- Vol. 75 (3) , 293-302
Pomegranate juice treatment reverses carbon tetrachloride (CCl4)-induced increased acetylcholinesterase activity and cell death via suppression of oxidative stress in rats
Background: Environmental pollution, including exposure to carbon tetrachloride (CCl4), poses serious health risks, particularly through oxidative stress, which may lead to neurodegenerative damage. Antioxidants, especially those found in natural products, show potential in mitigating these toxic effects. Pomegranate juice (PJ), rich in bioactive phytochemicals, has demonstrated antioxidant, anti-inflammatory, and neuroprotective properties.Objective: This study aimed to investigate the protective effects of PJ on neurotoxicity induced by CCl4 in rats, assessing specific markers of oxidative stress, enzymatic activity, and apoptotic cell death.Material and Methods: Twenty-eight male Wistar rats were divided into four groups: Control, CCl4, PJ, and CCl4+PJ. The CCl4 group received intraperitoneal injections of CCl4 (0.2 ml/100 g) twice weekly for six weeks, while the PJ group received PJ orally (4 ml/kg) daily for 30 days. The CCl4+PJ group received both treatments in sequence. Brain tissues were analysed for malondialdehyde (MDA), reduced glutathione (GSH), acetylcholinesterase (AChE), glutathione S-transferase (GST), glutathione reductase (GR), and carboxylesterase (CaE) activity. Apoptotic cell death was assessed using TUNEL staining.Results: CCl4 exposure resulted in a marked increase in MDA levels and AChE activity in brain tissue (p<0.05), alongside a significant decrease in reduced GSH levels and GST activity (p<0.05). Treatment with PJ significantly lowered MDA levels and AChE activity in the CCl4+PJ group compared to the CCl4 group (p<0.05). However, GSH levels and GST activity showed no significant changes in the CCl4+PJ group. TUNEL staining indicated a reduction in apoptotic cells in the CCl4+PJ group versus the CCl4 group, suggesting reduced cellular damage with PJ treatment (p<0.05).Conclusions: PJ demonstrates neuroprotective potential against CCl4-induced oxidative stress and neurotoxicity in rats by reducing oxidative markers and apoptosis. These findings suggest that PJ could serve as a natural protective agent against neurodegenerative risks associated with environmental pollutants like CCl4.
- 17 December 2024
- Published by National Institute of Public Health NIH (National Research Institute) in Roczniki Panstwowego Zakladu Higieny
- Vol. 75 (3) , 293-302
Pomegranate juice treatment reverses carbon tetrachloride (CCl4)-induced increased acetylcholinesterase activity and cell death via suppression of oxidative stress in rats
Background: Environmental pollution, including exposure to carbon tetrachloride (CCl4), poses serious health risks, particularly through oxidative stress, which may lead to neurodegenerative damage. Antioxidants, especially those found in natural products, show potential in mitigating these toxic effects. Pomegranate juice (PJ), rich in bioactive phytochemicals, has demonstrated antioxidant, anti-inflammatory, and neuroprotective properties.Objective: This study aimed to investigate the protective effects of PJ on neurotoxicity induced by CCl4 in rats, assessing specific markers of oxidative stress, enzymatic activity, and apoptotic cell death.Material and Methods: Twenty-eight male Wistar rats were divided into four groups: Control, CCl4, PJ, and CCl4+PJ. The CCl4 group received intraperitoneal injections of CCl4 (0.2 ml/100 g) twice weekly for six weeks, while the PJ group received PJ orally (4 ml/kg) daily for 30 days. The CCl4+PJ group received both treatments in sequence. Brain tissues were analysed for malondialdehyde (MDA), reduced glutathione (GSH), acetylcholinesterase (AChE), glutathione S-transferase (GST), glutathione reductase (GR), and carboxylesterase (CaE) activity. Apoptotic cell death was assessed using TUNEL staining.Results: CCl4 exposure resulted in a marked increase in MDA levels and AChE activity in brain tissue (p<0.05), alongside a significant decrease in reduced GSH levels and GST activity (p<0.05). Treatment with PJ significantly lowered MDA levels and AChE activity in the CCl4+PJ group compared to the CCl4 group (p<0.05). However, GSH levels and GST activity showed no significant changes in the CCl4+PJ group. TUNEL staining indicated a reduction in apoptotic cells in the CCl4+PJ group versus the CCl4 group, suggesting reduced cellular damage with PJ treatment (p<0.05).Conclusions: PJ demonstrates neuroprotective potential against CCl4-induced oxidative stress and neurotoxicity in rats by reducing oxidative markers and apoptosis. These findings suggest that PJ could serve as a natural protective agent against neurodegenerative risks associated with environmental pollutants like CCl4.
- Open Access
- 28 March 2024
- Published by The Nencki Institute of Experimental Biology, Polish Academy of Sciences in Acta Neurobiologiae Experimentalis
- Vol. 84 (1) , 35-42
Alarin potentiates ongoing epileptiform activity in rat brain slices: an in vitro electrophysiological study
Alarin is a newly discovered neuropeptide that belongs to the galanin peptide family with a wide range of bioactivity in the nervous system. Its function in the brain’s autonomic areas has been studied, and it has been reported that alarin is involved in the regulation of excitability in hypothalamic neurons. Its role in the regulation of excitability in the hippocampus, however, is unknown. In this study, we investigated if alarin induced any synchronous discharges or epileptiform activity, and if it had any effect on already initiated epileptiform discharges. We used thick acute horizontal hippocampal slices obtained from 30‑ to 35‑day‑old rats. Extracellular field potential recordings were evaluated in the CA1 region of the hippocampus. Our data demonstrated that, alarin application did not result in any epileptiform activity or abnormal discharges. 4‑aminopyridine was applied to induce epileptiform activity in the slices. We found that alarin increased the frequency of interictal‑like events and the mean power of local field potentials in the CA1 region of the hippocampus, which was induced by 4‑aminopyridine. These results demonstrated for the first time that alarin has a modulatory effect on synchronized neuronal discharges and showed the contribution of the neuropeptide alarin to epilepsy‑like conditions.
- 28 March 2024
- Published by The Nencki Institute of Experimental Biology, Polish Academy of Sciences in Acta Neurobiologiae Experimentalis
- Vol. 84 (1) , 35-42
Open AccessAlarin potentiates ongoing epileptiform activity in rat brain slices: an in vitro electrophysiological study
Alarin is a newly discovered neuropeptide that belongs to the galanin peptide family with a wide range of bioactivity in the nervous system. Its function in the brain’s autonomic areas has been studied, and it has been reported that alarin is involved in the regulation of excitability in hypothalamic neurons. Its role in the regulation of excitability in the hippocampus, however, is unknown. In this study, we investigated if alarin induced any synchronous discharges or epileptiform activity, and if it had any effect on already initiated epileptiform discharges. We used thick acute horizontal hippocampal slices obtained from 30‑ to 35‑day‑old rats. Extracellular field potential recordings were evaluated in the CA1 region of the hippocampus. Our data demonstrated that, alarin application did not result in any epileptiform activity or abnormal discharges. 4‑aminopyridine was applied to induce epileptiform activity in the slices. We found that alarin increased the frequency of interictal‑like events and the mean power of local field potentials in the CA1 region of the hippocampus, which was induced by 4‑aminopyridine. These results demonstrated for the first time that alarin has a modulatory effect on synchronized neuronal discharges and showed the contribution of the neuropeptide alarin to epilepsy‑like conditions.